RespireRx Pharmaceuticals Market Cap

RespireRx Pharmaceuticals has a market cap or net worth of $569.68 thousand as of May 9, 2025. Its market cap has decreased by -7.11% in one year.

Market Cap

569.68K

Enterprise Value

4.16M

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.00

Market Cap Chart

Since May 1, 1992, RespireRx Pharmaceuticals's market cap has decreased from 26.39M to 569.68K, a decrease of -97.84%. That is a compound annual growth rate of -10.96%.

Market Cap History

Date	Market Cap	% Change
May 7, 2025	569.68K	-25.00%
Dec 31, 2024	759.57K	65.58%
Dec 29, 2023	458.74K	58.87%
Dec 30, 2022	288.75K	-74.38%
Dec 31, 2021	1.13M	-45.46%
Dec 31, 2020	2.07M	411.01%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo Inc.	1.60B
Nika Pharmaceuticals	1.02B
Veradigm	761.86M
Tian'an Technology Group	568.98M
Glass House Brands	485.08M
Elite Pharmaceuticals	465.75M
CytoDyn	417.40M
Northwest Biotherapeutics	389.52M

Market Cap Rankings